UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic Advances in Acute Myeloid Leukemia

Journal of clinical oncology, 2011-02, Vol.29 (5), p.487-494

2011

Volltextzugriff (PDF)

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

Blood, 2015-02, Vol.125 (9), p.1367-1376

2015

Volltextzugriff (PDF)

Evolution of acute myelogenous leukemia stem cell properties after treatment and progression

Blood, 2016-09, Vol.128 (13), p.1671-1678

2016

Volltextzugriff (PDF)

Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4422-4432

2009

Volltextzugriff (PDF)

Omacetaxine as an anticancer therapeutic: what is old is new again

Current pharmaceutical design, 2011, Vol.17 (1), p.59-64

2011

Volltextzugriff (PDF)

Expression and prognostic impact of lncRNAs in acute myeloid leukemia

Proceedings of the National Academy of Sciences - PNAS, 2014-12, Vol.111 (52), p.18679-18684

2014

Volltextzugriff (PDF)

IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Journal of clinical oncology, 2010-05, Vol.28 (14), p.2348-2355

2010

Volltextzugriff (PDF)

Philadelphia chromosome‐positive acute lymphoblastic leukemia

Cancer, 2011-04, Vol.117 (8), p.1583-1594

2011

Volltextzugriff (PDF)

RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures

Journal of clinical oncology, 2012-09, Vol.30 (25), p.3109-3118

2012

Volltextzugriff (PDF)

TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Journal of clinical oncology, 2011-04, Vol.29 (10), p.1373-1381

2011

Volltextzugriff (PDF)

Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia

Journal of clinical oncology, 2012-03, Vol.30 (7), p.742-750

2012

Volltextzugriff (PDF)

Towards better combination regimens of cytarabine and FLT3 inhibitors in acute myeloid leukemia

Cancer chemotherapy and pharmacology, 2020-09, Vol.86 (3), p.325-337

2020

Volltextzugriff (PDF)

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2492-2499

2012

Volltextzugriff (PDF)

Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study

Journal of clinical oncology, 2010-02, Vol.28 (4), p.596-604

2010

Volltextzugriff (PDF)

Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4207-4213

2010

Volltextzugriff (PDF)

Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)

Haematologica (Roma), 2014-01, Vol.99 (1), p.111-115

2014

Volltextzugriff (PDF)

Activity of the Hypoxia-Activated Prodrug, TH-302, in Preclinical Human Acute Myeloid Leukemia Models

Clinical cancer research, 2013-12, Vol.19 (23), p.6506-6519

2013

Volltextzugriff (PDF)

Signal transducer and activator of transcription proteins in leukemias

Blood, 2003-04, Vol.101 (8), p.2940-2954

2003

Volltextzugriff (PDF)

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

The lancet oncology, 2012-11, Vol.13 (11), p.1096-1104

2012

Volltextzugriff (PDF)

High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4754-4759

2009

Volltextzugriff (PDF)

Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification

Haematologica (Roma), 2014-02, Vol.99 (2), p.308-313

2014

Volltextzugriff (PDF)

Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts

Haematologica (Roma), 2015-02, Vol.100 (2), p.e49

2015

Volltextzugriff (PDF)

Asparaginase allergies: it's all in the genes

Blood, 2014-08, Vol.124 (8), p.1206-1207

Wetzler, Meir

2014

Volltextzugriff (PDF)

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission

Blood, 2007-07, Vol.110 (1), p.409-417

2007

Volltextzugriff (PDF)

Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia

Leukemia research reports, 2017, Vol.7 (C), p.36-39

2017

Volltextzugriff (PDF)

1 – 25 von 320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(278)

Publikationsform

Sprache

Englisch
(320)

Erscheinungsjahr

n.n

Thema

Humans
(169)
Science & Technology
(159)
Life Sciences & Biomedicine
(156)
Oncology
(101)
Female
(95)
Male
(89)
Middle Aged
(87)
Hematology
(82)
Adult
(81)
Biological And Medical Sciences
(75)
Medical Sciences
(74)
Aged
(73)
Hematologic And Hematopoietic Diseases
(56)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(53)
Aged, 80 And Over
(43)
Hematology, Oncology And Palliative Medicine
(43)
Treatment Outcome
(37)
Prognosis
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(31)
Leukemia, Myeloid, Acute - Drug Therapy
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic Advances in Acute Myeloid Leukemia

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

Evolution of acute myelogenous leukemia stem cell properties after treatment and progression

Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias

Omacetaxine as an anticancer therapeutic: what is old is new again

Expression and prognostic impact of lncRNAs in acute myeloid leukemia

IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Philadelphia chromosome‐positive acute lymphoblastic leukemia

RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures

TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia

Towards better combination regimens of cytarabine and FLT3 inhibitors in acute myeloid leukemia

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study

Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study

Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)

Activity of the Hypoxia-Activated Prodrug, TH-302, in Preclinical Human Acute Myeloid Leukemia Models

Signal transducer and activator of transcription proteins in leukemias

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses

Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification

Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts

Asparaginase allergies: it's all in the genes

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission

Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia

Suchergebnisse filtern